Lactose, Sucrose & Corn Syrup Tolerance

July 3, 2014 updated by: University of British Columbia

Lactose: A Unique Carbohydrate Enabling Homeostatic Regulation of Blood Glucose & Insulin

Lactose, one of the key nutrients in human milk may be critically important to infants for more reasons than being a source of energy. We are interested in understanding how lactose when compared to other sugars influences how nutrients, specifically macronutrients are handled after digestion and absorption. To date, there have been no studies looking at how fat and protein varies when lactose compared to other sugars is ingested. There may be metabolic advantages to considering lactose for nutrition support of premature infants rather than glucose or dextrose as is often used in intravenous feeds, or the corn syrup solids in lactose-free formulas. We hope the information from this study will provide new information on the unique aspects of lactose.

Hypothesis: The hypothesis is that providing carbohydrate as lactose:

  1. minimizes the amount of carbohydrate that is converted into fat
  2. enables a relatively constant metabolic state throughout feeding interval that avoids swings of high to low insulin, glucose, and fats.

Study Overview

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z4H4
        • Child & Family Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • male
  • at least 19 years of age
  • body mass index (BMI) between 18.5 and 25
  • fasting blood glucose level < 6.1 mmol/L (110 mg/dL) measured by glucometer on the day of the study and
  • comfortable speaking, reading and understanding English
  • comfortable drinking at least one cup (250 ml) of milk
  • non-smoking

Exclusion Criteria:

  • not willing to provide blood samples, have
  • impaired lactose or glucose tolerance,
  • pre-diabetes, diabetes mellitus and any other endocrine disorder,
  • coronary heart disease, liver function test abnormalities or any chronic disease
  • routinely take medications, including aspirin, cyclooxygenase-2 inhibitors, statins and fish oil
  • consuming more than 1 alcoholic drink per day

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: corn syrup solids
corn syrup solids oral ingestion
oral ingestion 50 grams, 2 doses
Other Names:
  • corn syrup
Experimental: sucrose
sucrose oral ingestion
oral ingestion 50 grams, 2 doses

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial changes in plasma insulin, glucagon, triglycerides and amino acids.
Time Frame: 6 hours
Area under the curve changes in the outcome measures following oral ingestion.
6 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial changes in plasma fatty acids.
Time Frame: 6 hours
Area under the curve analyses of changes in plasma fatty acids following oral ingestion
6 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sheila M Innis, PhD, University of British Columbia, Child & Family Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

June 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

December 20, 2012

First Submitted That Met QC Criteria

February 8, 2013

First Posted (Estimate)

February 12, 2013

Study Record Updates

Last Update Posted (Estimate)

July 4, 2014

Last Update Submitted That Met QC Criteria

July 3, 2014

Last Verified

July 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • H12-01647

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on corn syrup solids

3
Subscribe